Table 1.
Correlation between USP5 expression and clinicopathological features of patients with pancreatic cancer
| Clinicopathological feature | USP5 expression | P value | |
|---|---|---|---|
| Low | High | ||
| Age (years) | 0.8877 | ||
| ≤50 | 8 | 14 | |
| >50 | 25 | 47 | |
| Sex | 0.3789 | ||
| Male | 22 | 35 | |
| Female | 11 | 26 | |
| Tumor site | 0.6346 | ||
| Pancreatic head | 19 | 32 | |
| Pancreatic body and tail | 14 | 29 | |
| Differentiation | 0.02359 | ||
| High differentiation | 10 | 7 | |
| Middle and low differentiation | 23 | 54 | |
| T stage | 0.3868 | ||
| T1.2 | 9 | 22 | |
| T3.4 | 24 | 39 | |
| N stage | 0.9941 | ||
| N0 | 30 | 54 | |
| N1 | 3 | 7 | |
| M stage | 1.0000 | ||
| M0 | 32 | 59 | |
| M1 | 1 | 2 | |
| AJCC (pTNM) | 0.9508 | ||
| Ⅰ | 9 | 17 | |
| ⅡⅢⅣ | 24 | 44 | |
| CEA | 0.0324 | ||
| Normal | 28 | 39 | |
| Abnormal | 5 | 22 | |
| CA199 | 0.0133 | ||
| Normal | 13 | 10 | |
| Abnormal | 20 | 51 | |